Pharmaceuticals

Cell Therapy Market Forecast: What to Expect by 2029

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Cell Therapy Market By 2029?

The cell therapy market has experienced significant expansion in recent years. This market is set to increase from $14.56 billion in 2024 to $16.87 billion in 2025, showing a compound annual growth rate (CAGR) of 15.8%. Historically, the factors contributing to this growth include early research and discoveries, key regulatory milestones, extensive clinical trials and studies, the initiatives of early adopters and pioneering companies, and rising market acceptance and perception.

The cell therapy market is projected to undergo significant expansion in the coming years, with its size expected to reach $28.67 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.2%. This growth during the forecast period is primarily driven by ethical and societal considerations, evolving investment and funding patterns, increasing consumer and patient demand, enhancements in healthcare infrastructure, and swift innovation cycles. Notable trends anticipated for this period encompass personalized medicine, the emergence of targeted treatments, advancements in gene editing technologies, the broadening of stem cell research, improvements in immunotherapy, and strategies for microenvironment manipulation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Cell Therapy Industry?

The increasing occurrence of chronic illnesses has significantly propelled the expansion of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a condition persisting for a year or longer, often necessitating medical intervention, limiting daily activities, or both, and encompassing ailments like heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells offer therapeutic promise for patients with conditions such as spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, the Centers for Disease Control and Prevention (CDC), a US national public health agency, released important updates regarding public health initiatives, highlighting critical statistics. Annually, over 944,800 Americans succumb to heart disease or stroke, constituting more than one-third of all fatalities. In the U.S., 1.7 million individuals are diagnosed with cancer each year, with over 600,000 fatalities, positioning it as the second leading cause of death. Furthermore, more than 38 million Americans live with diabetes, and an additional 98 million adults are prediabetic, raising their risk for type 2 diabetes. Diabetes can lead to severe health issues including heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, thereby escalating the risk of chronic ailments like type 2 diabetes, heart disease, and specific cancers. Ultimately, the growing incidence of chronic diseases has heightened the demand for cell therapies, contributing to the overall growth of the cell therapy market.

What Are The Segment Types Shaping The Cell Therapy Market?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

How Are Emerging Market Trends Shaping The Cell Therapy Industry Landscape?

Leading industry participants are forming strategic alliances and engaging in collaborations to broaden their product offerings and extend their global reach. As of November 2023, Ajinomoto Co Inc., a Japanese food enterprise, completed the acquisition of Forge Biologics for $620 million. This acquisition is intended to strengthen Ajinomoto Co Inc.’s worldwide expertise in AAV and plasmid gene therapy production, thereby enhancing and reinforcing its current contract development and manufacturing services. Forge Biologics, an American biotechnology firm, specializes in developing innovative cell therapy technologies to address a range of illnesses.

Who Are The Primary Competitors In The Global Cell Therapy Market?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Regional Markets Are Contributing Most To The Cell Therapy Industry Expansion?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cell Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2025, By The Business Research Company

Flow Cytometry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Nucleic Acid Based Gene Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795